Fora Capital, LLC Bridge Bio Pharma, Inc. Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $850,668 - $1.55 Million	35,415 New	35,415 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$46.87 - $64.24 $95,286 - $130,599	-2,033 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $13,987 - $19,242	-301 Reduced 12.9%	2,033 $124 Million
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $478,484 - $624,091	-8,626 Reduced 78.7%	2,334 $144 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $276,796 - $512,845	7,212 Added 192.42%	10,960 $779,000
Q3 2020 Nov 13, 2020	BUY	$27.2 - $42.19 $32,558 - $50,501	1,197 Added 46.92%	3,748 $141 Million
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $56,683 - $91,045	2,551 New	2,551 $83 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.